Neutral
AI recommendation signal analysis across 307 domains for the Neutral persona in Weight Loss Clinics GLP-1 Telehealth.
This report tracks how AI models and search engines recommend companies across 100 industries. If you want the same analysis run specifically against your own site and competitors, get in touch.
Get in touch →How to use this page
Pick the right events
The conferences and trade shows search associates with this industry. Use it to choose where to attend, exhibit, sponsor, or pitch a talk.
Where the numbers come from
We run conferences, trade shows queries for this industry through Google and aggregate every result: domains by rank-weighted score (higher positions count for more) and appearance count, exact URLs by appearance count, and the most common title phrases.
What's on this page
Domain and URL charts, the full result list, and title n-gram tables.
Research: Conferences, Trade Shows
Domains appearing in Google results for Neutral's Research: Conferences, Trade Shows queries. Score is a rank-weighted sum (higher-ranked appearances count for more); count is a plain appearance tally.
Top URLs
Individual pages (not just domains) ranked by the same rank-weighted score, labeled by page title.
All Results
Every result for Neutral's Research: Conferences, Trade Shows queries, ranked by how many times each exact URL appeared (ties broken by average rank position, so appearing higher up wins), a different aggregation than the score-based charts above. Title and URL links open in a new tab.
Title N-Grams
Most common word phrases (2 to 7 words) across every result title for these queries.
2-grams
| 70 | glp 1 |
| 23 | weight loss |
| 11 | of glp |
| 9 | 1 drugs |
| 8 | glp 1s |
| 7 | 1 weight |
| 5 | loss drugs |
| 4 | the glp |
| 4 | for weight |
| 4 | loss and |
| 4 | and the |
| 4 | on glp |
| 4 | and glp |
| 4 | 1 agonists |
| 4 | 1 medications |
| 4 | the weight |
| 3 | weight management |
| 3 | in obesity |
| 3 | 1 era |
| 3 | for glp |
| 3 | 1 therapies |
| 3 | of weight |
| 3 | and health |
| 2 | summit 2026 |
| 2 | 1 revolution |
3-grams
| 10 | of glp 1 |
| 9 | glp 1 drugs |
| 7 | glp 1 weight |
| 6 | 1 weight loss |
| 5 | weight loss drugs |
| 4 | the glp 1 |
| 4 | weight loss and |
| 4 | glp 1 agonists |
| 4 | glp 1 medications |
| 3 | for weight loss |
| 3 | glp 1 era |
| 3 | and glp 1 |
| 3 | glp 1 therapies |
| 3 | on glp 1 |
| 3 | the weight loss |
| 2 | glp 1 revolution |
| 2 | glp 1 obesity |
| 2 | to know about |
| 2 | for glp 1s |
| 2 | new glp 1 |
| 2 | glp 1 drug |
| 2 | glp 1 gip |
| 2 | after glp 1 |
| 2 | glp 1 law |
| 2 | 1 law policy |
4-grams
| 6 | glp 1 weight loss |
| 2 | the glp 1 revolution |
| 2 | glp 1 law policy |
| 2 | of glp 1 drugs |
| 2 | glp 1 drugs and |
| 2 | coverage of glp 1 |
| 2 | 1 weight loss drugs |
| 2 | weight loss and health |
| 2 | employers in a bind |
| 2 | in a bind over |
| 1 | home 3rd glp 1 |
| 1 | 3rd glp 1 based |
| 1 | glp 1 based therapeutics |
| 1 | 1 based therapeutics summit |
| 1 | based therapeutics summit 2026 |
| 1 | weight loss drug development |
| 1 | loss drug development summit |
| 1 | drug development summit obesity |
| 1 | development summit obesity conference |
| 1 | discover the glp 1 |
| 1 | glp 1 revolution at |
| 1 | 1 revolution at obesityweek |
| 1 | revolution at obesityweek 2025 |
| 1 | at obesityweek 2025 in |
| 1 | weight management summit 2026 |
5-grams
| 2 | glp 1 weight loss drugs |
| 2 | employers in a bind over |
| 1 | home 3rd glp 1 based |
| 1 | 3rd glp 1 based therapeutics |
| 1 | glp 1 based therapeutics summit |
| 1 | 1 based therapeutics summit 2026 |
| 1 | weight loss drug development summit |
| 1 | loss drug development summit obesity |
| 1 | drug development summit obesity conference |
| 1 | discover the glp 1 revolution |
| 1 | the glp 1 revolution at |
| 1 | glp 1 revolution at obesityweek |
| 1 | 1 revolution at obesityweek 2025 |
| 1 | revolution at obesityweek 2025 in |
| 1 | weight management summit 2026 home |
| 1 | management summit 2026 home page |
| 1 | nabip tx conference liviniti experts |
| 1 | tx conference liviniti experts present |
| 1 | conference liviniti experts present glp |
| 1 | liviniti experts present glp 1 |
| 1 | emerging frontiers in obesity clinical |
| 1 | frontiers in obesity clinical research |
| 1 | in obesity clinical research the |
| 1 | obesity clinical research the impact |
| 1 | how supply and demand for |
6-grams
| 1 | home 3rd glp 1 based therapeutics |
| 1 | 3rd glp 1 based therapeutics summit |
| 1 | glp 1 based therapeutics summit 2026 |
| 1 | weight loss drug development summit obesity |
| 1 | loss drug development summit obesity conference |
| 1 | discover the glp 1 revolution at |
| 1 | the glp 1 revolution at obesityweek |
| 1 | glp 1 revolution at obesityweek 2025 |
| 1 | 1 revolution at obesityweek 2025 in |
| 1 | weight management summit 2026 home page |
| 1 | nabip tx conference liviniti experts present |
| 1 | tx conference liviniti experts present glp |
| 1 | conference liviniti experts present glp 1 |
| 1 | emerging frontiers in obesity clinical research |
| 1 | frontiers in obesity clinical research the |
| 1 | in obesity clinical research the impact |
| 1 | how supply and demand for weight |
| 1 | supply and demand for weight loss |
| 1 | and demand for weight loss drugs |
| 1 | demand for weight loss drugs is |
| 1 | for weight loss drugs is playing |
| 1 | bending the cost curve understanding the |
| 1 | the cost curve understanding the glp |
| 1 | cost curve understanding the glp 1 |
| 1 | curve understanding the glp 1 era |
7-grams
| 1 | home 3rd glp 1 based therapeutics summit |
| 1 | 3rd glp 1 based therapeutics summit 2026 |
| 1 | weight loss drug development summit obesity conference |
| 1 | discover the glp 1 revolution at obesityweek |
| 1 | the glp 1 revolution at obesityweek 2025 |
| 1 | glp 1 revolution at obesityweek 2025 in |
| 1 | nabip tx conference liviniti experts present glp |
| 1 | tx conference liviniti experts present glp 1 |
| 1 | emerging frontiers in obesity clinical research the |
| 1 | frontiers in obesity clinical research the impact |
| 1 | how supply and demand for weight loss |
| 1 | supply and demand for weight loss drugs |
| 1 | and demand for weight loss drugs is |
| 1 | demand for weight loss drugs is playing |
| 1 | bending the cost curve understanding the glp |
| 1 | the cost curve understanding the glp 1 |
| 1 | cost curve understanding the glp 1 era |
| 1 | affordable access to glp 1 obesity medications |
| 1 | access to glp 1 obesity medications pmc |
| 1 | to glp 1 obesity medications pmc nih |
| 1 | glp 1 induced weight loss and the |
| 1 | 1 induced weight loss and the female |
| 1 | induced weight loss and the female obesity |
| 1 | weight loss and the female obesity penalty |
| 1 | what you need to know about eating |